慢性移植物抗宿主病对急性髓系白血病患者复发及生存的影响

目的 探讨慢性移植物抗宿主病(cGVHD)对造血干细胞移植(HSCT)后急性髓系白血病(AML)患者复发及生存的影响.方法 回顾性分析接受异基因外周血HSCT的55例发生cGVHD及未发生cGVHD的AML患者复发及生存情况.结果 cGVHD组移植后2年内的AML复发率显著低于未发生cGVHD组(8.7%对38.6%,P=0.019),而2年后远期复发率与对照组比较差异无统计学意义(22.8%对5.9%,P=0.217);移植后2年内的生存率差异无统计学意义(78.3%、61.0%,P=0.155),远期生存率cGVHD组明显降低(63.7%对100%,P=0.011).在难治复发的高危AML...

Full description

Saved in:
Bibliographic Details
Published in中华血液学杂志 Vol. 36; no. 2; pp. 116 - 120
Main Author 赵小利 魏华萍 赵莎莎 李红华 靖彧 黄文荣 赵瑜 王全顺 于力 高春记
Format Journal Article
LanguageChinese
Published 解放军总医院、解放军医学院血液科, 北京,100853 2015
Subjects
Online AccessGet full text
ISSN0253-2727
DOI10.3760/cma.j.issn.0253-2727.2015.02.007

Cover

Abstract 目的 探讨慢性移植物抗宿主病(cGVHD)对造血干细胞移植(HSCT)后急性髓系白血病(AML)患者复发及生存的影响.方法 回顾性分析接受异基因外周血HSCT的55例发生cGVHD及未发生cGVHD的AML患者复发及生存情况.结果 cGVHD组移植后2年内的AML复发率显著低于未发生cGVHD组(8.7%对38.6%,P=0.019),而2年后远期复发率与对照组比较差异无统计学意义(22.8%对5.9%,P=0.217);移植后2年内的生存率差异无统计学意义(78.3%、61.0%,P=0.155),远期生存率cGVHD组明显降低(63.7%对100%,P=0.011).在难治复发的高危AML患者中,cGVHD组与未发生cGVHD组比较,移植后2年内AML复发率低(8.3%对46.2%,P=0.044),生存率高(83.3%对47.2%,P=0.045);在中低危AML患者中,有或无cGVHD其复发率及生存率均无显著变化(P=0.266,P=0.289).局限型及广泛型cGVHD患者中,移植后复发率分别为27.3%和31.3%,较未发生cGVHD患者复发率(42.2%)均下降;但广泛型cGVHD患者远期生存率降低(53.3%,P=0.001).结论 cGVHD降低AML复发的保护作用主要发生在移植后早期(2年),尤其使得难治复发的高危AML患者受益;而在移植晚期,cGVHD尤其广泛型cGVHD与移植相关死亡率相关,明显降低远期生存率.
AbstractList 目的 探讨慢性移植物抗宿主病(cGVHD)对造血干细胞移植(HSCT)后急性髓系白血病(AML)患者复发及生存的影响.方法 回顾性分析接受异基因外周血HSCT的55例发生cGVHD及未发生cGVHD的AML患者复发及生存情况.结果 cGVHD组移植后2年内的AML复发率显著低于未发生cGVHD组(8.7%对38.6%,P=0.019),而2年后远期复发率与对照组比较差异无统计学意义(22.8%对5.9%,P=0.217);移植后2年内的生存率差异无统计学意义(78.3%、61.0%,P=0.155),远期生存率cGVHD组明显降低(63.7%对100%,P=0.011).在难治复发的高危AML患者中,cGVHD组与未发生cGVHD组比较,移植后2年内AML复发率低(8.3%对46.2%,P=0.044),生存率高(83.3%对47.2%,P=0.045);在中低危AML患者中,有或无cGVHD其复发率及生存率均无显著变化(P=0.266,P=0.289).局限型及广泛型cGVHD患者中,移植后复发率分别为27.3%和31.3%,较未发生cGVHD患者复发率(42.2%)均下降;但广泛型cGVHD患者远期生存率降低(53.3%,P=0.001).结论 cGVHD降低AML复发的保护作用主要发生在移植后早期(2年),尤其使得难治复发的高危AML患者受益;而在移植晚期,cGVHD尤其广泛型cGVHD与移植相关死亡率相关,明显降低远期生存率.
目的 探讨慢性移植物抗宿主病(cGVHD)对造血干细胞移植(HSCT)后急性髓系白血病(AML)患者复发及生存的影响.方法 回顾性分析接受异基因外周血HSCT的55例发生cGVHD及未发生cGVHD的AML患者复发及生存情况.结果 cGVHD组移植后2年内的AML复发率显著低于未发生cGVHD组(8.7%对38.6%,P=0.019),而2年后远期复发率与对照组比较差异无统计学意义(22.8%对5.9%,P=0.217);移植后2年内的生存率差异无统计学意义(78.3%、61.0%,P=0.155),远期生存率cGVHD组明显降低(63.7%对100%,P=0.011).在难治复发的高危AML患者中,cGVHD组与未发生cGVHD组比较,移植后2年内AML复发率低(8.3%对46.2%,P=0.044),生存率高(83.3%对47.2%,P=0.045);在中低危AML患者中,有或无cGVHD其复发率及生存率均无显著变化(P=0.266,P=0.289).局限型及广泛型cGVHD患者中,移植后复发率分别为27.3%和31.3%,较未发生cGVHD患者复发率(42.2%)均下降;但广泛型cGVHD患者远期生存率降低(53.3%,P=0.001).结论 cGVHD降低AML复发的保护作用主要发生在移植后早期(2年),尤其使得难治复发的高危AML患者受益;而在移植晚期,cGVHD尤其广泛型cGVHD与移植相关死亡率相关,明显降低远期生存率.
Abstract_FL Objective To explore the influence of relapse and survival by chronic graft versus host disease (cGVHD) in patients with acute myeloid leukemia (AML) after allogeneic hematopoietics stem cell transplantation (allo-HSCT).Methods Fifty-five AML patients received allo-HSCT were retrospectively reviewed.Relapse rate and overall survival (OS) were analyzed according to cGVHD.Results cGVHD significantly decreased the relapse rate of AML patients after transplantation within 2 years when compared with those without cGVHD (8.7% vs 38.6%,P=0.019),however,cGVHD had no effect on the long-term relapse rate (22.8% vs 5.9%,P=0.217).cGVHD had no effect on OS within 2 years (78.3% vs 61.0%,P=0.155) but could decrease the rate of long-term survival (63.7% vs 100%,P=0.01).cGVHD also could reduce the rate of relapse (8.3% vs 46.2%,P=0.044) and enhanced the rate of survival (83.3% vs 47.2%,P=0.045) in patients with high risk AML after allo-HSCT in 2 years,while it had no effect on the relapse rate and OS in patients with low and intermediated risk AML in early and late phase.Moreover,compared with the rate of relapse (38.6%) in patients without cGVHD,the rate of relapse were lower in patients with limited cGVHD and intensive cGVHD (27.3% and 31.3%,respectively) but the long-term survival was significantly lower (53.3%,P=0.001) in those patients with intensive cGVHD after all-HSCT.Conclusion The benefit effect of cGVHD mainly took place within 2 years after allo-HSCT in AML patients especially in those with high risk,while in late phase after allo-HSCT,cGVHD especially intensive cGVHD had an effect on reducing long-term survival.
Author 赵小利 魏华萍 赵莎莎 李红华 靖彧 黄文荣 赵瑜 王全顺 于力 高春记
AuthorAffiliation 解放军总医院、解放军医学院血液科,北京100853
AuthorAffiliation_xml – name: 解放军总医院、解放军医学院血液科, 北京,100853
Author_xml – sequence: 1
  fullname: 赵小利 魏华萍 赵莎莎 李红华 靖彧 黄文荣 赵瑜 王全顺 于力 高春记
BookMark eNo9j01LAkEcxudgkFpfokN0cZudmZ2ZPYb0BkIE3mV21vWFXMsl0k5L5CFBJAysLlEZElERXQqRvkyza9-iiaLTw_95fvwfnhRI-HW_CMCSCQ3MKFyWNWFUjUoQ-AZEFs4ghpiBoGnp04CQJUDy358FqSCoQkh0TpJgO2rfROEoHo2jYTc-uY86A_X08fk2jgdt9fwehXc6_Xrox6_j-GIyvQ61Hx3dTsO2GnZV71T1OvHZlXo8jy-P1eRF9btzYMYTO0Fx_k_TIL-2ms9uZHJb65vZlVxGWpxlCOLQpVhwSTzGuWs7FuWICmhJl1AEHZO7QnJEJGGmy6CDqO1Qz0YESu4UMU6Dxd-3B8L3hF8qVOv7DV8XFg7LzVbzZz1EersGF35BWa77pb2KRncblZpotAqUYs6obWL8DUuMfKA
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.issn.0253-2727.2015.02.007
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Effect of chronic graft versus host disease on relapse and survival in patients with acute myeloid leukemia
DocumentTitle_FL Effect of chronic graft versus host disease on relapse and survival in patients with acute myeloid leukemia
EndPage 120
ExternalDocumentID zhxyx201502007
663876913
GrantInformation_xml – fundername: 国家自然科学基金
  funderid: (81270642)
GroupedDBID ---
-05
2B.
2C~
2RA
92F
92I
92L
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CQIGP
CW9
F5P
OK1
RPM
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
ABJNI
PSX
ID FETCH-LOGICAL-c587-4280d63a8c4f788d9b56826a05cd4620b18dac824c471d70b269b6f9240c8be33
ISSN 0253-2727
IngestDate Thu May 29 04:03:10 EDT 2025
Wed Feb 14 10:38:01 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 2
Keywords Graft versus host disease,chronic
移植物抗宿主病,慢性
Relapse
生存
Leukemia,myeloid,acute
白血病,髓样,急性
Survival
复发
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c587-4280d63a8c4f788d9b56826a05cd4620b18dac824c471d70b269b6f9240c8be33
Notes Graft versus host disease,chronic;Leukemia,myeloid,acute;Relapse;Survival
Zhao Xiaoli, Wei Huaping, Zhao Shasha, Li Honghua, Jing Yu, Huang Wenrong, Zhao Yu, Wang Quanshun, Yu Li, Gao Chunji. (Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China)
12-1090/R
Objective To explore the influence of relapse and survival by chronic graft versus host disease (cGVHD) in patients with acute myeloid leukemia (AML) after allogeneic hematopoietics stem cell transplantation (allo-HSCT).Methods Fifty-five AML patients received allo-HSCT were retrospectively reviewed.Relapse rate and overall survival (OS) were analyzed according to cGVHD.Results cGVHD significantly decreased the relapse rate of AML patients after transplantation within 2 years when compared with those without cGVHD (8.7% vs 38.6%,P=0.019),however,cGVHD had no effect on the long-term relapse rate (22.8% vs 5.9%,P=0.217).cGVHD had no effect on OS within 2 years (78.3% vs 61.0%,P=0.155) but could decrease the rate of long-term survival (63
PageCount 5
ParticipantIDs wanfang_journals_zhxyx201502007
chongqing_primary_663876913
PublicationCentury 2000
PublicationDate 2015
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – year: 2015
  text: 2015
PublicationDecade 2010
PublicationTitle 中华血液学杂志
PublicationTitleAlternate Chinese Journal of Hematology
PublicationTitle_FL Chinese Journal of Hematology
PublicationYear 2015
Publisher 解放军总医院、解放军医学院血液科, 北京,100853
Publisher_xml – name: 解放军总医院、解放军医学院血液科, 北京,100853
SSID ssj0042014
ssib051368330
ssib017477332
ssib001103535
ssib058574913
Score 2.0114365
Snippet 目的 探讨慢性移植物抗宿主病(cGVHD)对造血干细胞移植(HSCT)后急性髓系白血病(AML)患者复发及生存的影响.方法 回顾性分析接受异基因外周血HSCT的55例发生cGVHD及未发生cGVHD的AML患者复发及生存情况.结果...
目的 探讨慢性移植物抗宿主病(cGVHD)对造血干细胞移植(HSCT)后急性髓系白血病(AML)患者复发及生存的影响.方法 回顾性分析接受异基因外周血HSCT的55例发生cGVHD及未发生cGVHD的AML患者复发及生存情况.结果...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 116
SubjectTerms 复发
生存
白血病,髓样,急性
移植物抗宿主病,慢性
Title 慢性移植物抗宿主病对急性髓系白血病患者复发及生存的影响
URI http://lib.cqvip.com/qk/93752X/201502/663876913.html
https://d.wanfangdata.com.cn/periodical/zhxyx201502007
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEA-1gvgiioq1fvTBBeG4mq_9ekyaHEVQECr07cjHXYvg1Y8Wap8OsQ8WSpEKVV9ErRQRFfFFKaX_jLmr_4Uzk-QaVPyCEJaZ2d_M7iSZ2WR3YxgXWpHdhqiQ1rVo67rbguGOiixeNyFZtnQUuwmt4r9yVUxedy9P8-mhA7uVWUsL8_F4svTLdSX_41WggV9xlew_eHYACgQog3_hDB6G81_5mIWCKc48mwom8yQLJZ59Hyke5IkBUpRmniYZj2mQgSoh8xssdJmvSFgiHaCQ1WC-LgF5BRlAfKYdFPadspZmPqhQzLNQbB8HatnMc5AF9AI5t4cz1WDaKgpgEtZymW6QTMC0IorHlIsUwPdJGFSroJpMF_Z7OWbAVFixRDAfDrvA9ARSdIBWISYYMAjAWMnneCDHRKMQD5B0jVodlKRShQahoFapp5CR86hQK7WF1FseuagAIEzgaVG0zpNEgg7FBgtkKElQwHOqaiR2m56okU9Bj0-g0EBFdlqgqUad4pFmTv72a6XrFKEr8qqiS8CsvvTJF7wWUcHmTt2W-YYKZQjL95ApblW7Eo8sS1RSG4vWHf4UNXFeFFzqyc1o_AYpGR8owbmPPN_UVu5nDIN5nJCuQjTV-Nfog7aUFv_hdRnklg7fz8dh9CtlZb88bjlC0ezmPHVyQRvt91aqP2RcLOy79CfrcG-U2bnOzG3I-GgBXqcddWYqueLUUeNIMcgb8_I79pgxtDR73LjWW37Z6271t7Z7m6v9h296KxvZ-92vn7f7G8vZhy-97mvgfnu73v-03X-6s_eiC_Te_Vd73eVsczVbe5StrfQfP8_ePek_e5DtfMzWV08YU41wamKyXvzQpJ5wiOUw0jdT4UQqcdtSqVTHXMDoPjJ5krrCNmNLpVGibDeBjDGVZmwLHcMjFJLuRMUtxzlpDHfmOq1TxpgrVCIt0XIBzTVbdtyOlZOmgseJGadOMmKMDnqjeSvft6Y58NaIcb7on2bxNLvbXJpdvLeI_Wni14vTv60_ahxGyfxN5BljeP7OQuss5Obz8Tny_3fsja0H
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%85%A2%E6%80%A7%E7%A7%BB%E6%A4%8D%E7%89%A9%E6%8A%97%E5%AE%BF%E4%B8%BB%E7%97%85%E5%AF%B9%E6%80%A5%E6%80%A7%E9%AB%93%E7%B3%BB%E7%99%BD%E8%A1%80%E7%97%85%E6%82%A3%E8%80%85%E5%A4%8D%E5%8F%91%E5%8F%8A%E7%94%9F%E5%AD%98%E7%9A%84%E5%BD%B1%E5%93%8D&rft.jtitle=%E4%B8%AD%E5%8D%8E%E8%A1%80%E6%B6%B2%E5%AD%A6%E6%9D%82%E5%BF%97&rft.au=%E8%B5%B5%E5%B0%8F%E5%88%A9+%E9%AD%8F%E5%8D%8E%E8%90%8D+%E8%B5%B5%E8%8E%8E%E8%8E%8E+%E6%9D%8E%E7%BA%A2%E5%8D%8E+%E9%9D%96%E5%BD%A7+%E9%BB%84%E6%96%87%E8%8D%A3+%E8%B5%B5%E7%91%9C+%E7%8E%8B%E5%85%A8%E9%A1%BA+%E4%BA%8E%E5%8A%9B+%E9%AB%98%E6%98%A5%E8%AE%B0&rft.date=2015&rft.issn=0253-2727&rft.volume=36&rft.issue=2&rft.spage=116&rft.epage=120&rft_id=info:doi/10.3760%2Fcma.j.issn.0253-2727.2015.02.007&rft.externalDocID=663876913
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F93752X%2F93752X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhxyx%2Fzhxyx.jpg